This is a new and exciting procedure that was recently approved by the FDA. It has been shown to help prevent keratoconus from getting worse. We are now doing corneal cross-linking at our practice and are currently taking names. People of all ages may be eligible. To find out more please give our office a call.
Corneal Cross-Linking with Riboflavin is a treatment shown to slow or halt the progression of keratoconus. It does so by increasing the strength of corneal tissue. Undergoing corneal cross-linking in the early stages may help stabilize vision. While the treatment will not correct vision or eliminate the need for glasses and/or contact lenses, it can help maintain the current level of vision and is meant to prevent vision from worsening.
KXL® System Using Photexra® by Avedro
The surface skin of the eye is gently polished.
Riboflavin drops are applied to the eye.
UV-A light is applied to the eye.
A bandage contact lens is put in place to assist the initial healing process.
How Corneal Cross-Linking Works
The procedure involves treating the eyes with riboflavin—vitamin B2—drops, and then exposing the cornea to 30 minutes of UV-A light. When combined with riboflavin, the UV-A light causes a reaction that increases the collagen bonds in the cornea which have been weakened by keratoconus. The treatment induces the natural anchors within the corneal fibers to link and prevent more bulging. Cross-linked corneal fibers actually occur naturally with aging. Corneal cross-linking helps speed up that process, and intensifies it.
Benefits of Corneal Cross-Linking
- It helps prevent further deterioration of vision
- Prevention of keratoconus disease progression
- Greater corneal rigidity, increased corneal resistance and biomechanical stability
- May defer the need for a corneal transplant procedure
- May reduce myopia (nearsightedness) and astigmatism associated with keratoconus
- Does not prevent other corneal procedures from being done